|
1. CDC. Preventing emerging infectious diseases: a strategy for the 21st century. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1998. 2. Ma L, Xie L, Dong X, Shi W. Role of extracellular phospholipase B of Candida albicans as a virulent factor in experimental keratomycosis. Curr Eye Res 2009; 34(9): 761-8. 3. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol. 2007; 45(11): 3522-28. doi:10.1128/JCM.00403-07 4. Nowrozi H, Kazemi D, Kazemi A, Khaji L. [Effect of Amphotericin B and Fluconazole on hospital wards fungi]. J Gorgan Uni Med Sci. 2015; 16(4): 121-25. [Article in Persian] 5. Nowrozi H, Kazemi A, Teshfam M, Temorian Sh, Adimi P, Bashashati M. [Efficacy of ultraviolet radiation on drug susceptibility of Candida Spp. to itraconazole, fluconazole and amphotericin B]. J Gorgan Uni Med Sci. 2013; 15(4): 53-58. [Article in Persian] 6. NCCLS, Reference method for broth dilution antifungal susceptibility testing of yeast fungi. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA. NCCLS. 2002. 7. Razzaghi-Abyaneh M, Sadeghi G, Zeinali E, Alirezaee M, Shams-Ghahfarokhi M, Amani A, et al. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. J Mycol Med. 2014 Jun; 24(2): e43-50. doi:10.1016/j.mycmed.2014.01.004 8. Salehi Z, Seifi Z, Mahmoudabadi A. Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran. Jundishapur J Microbiol. 2012; 5(4): 574-77. doi:10.5812/jjm.4556 9. Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Rahimi Ghiasi M, Rezashah H. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J Glob Infect Dis. 2011; 3(4): 357-60. doi:10.4103/0974-777X.91059 10. Hasanbeigi A, Shahmir P, Amraie M. Study of antifungal resistance of Candida types against some of common antifungal drugs. Int J Pharm Sci Res. 2015; 6(2): 241-44. 11. Akbarzadeh M, Bonyadpoure B, Pacshir K, Mohagheghzadeh A. [Causes and clinical symptoms of vaginal candidiasis in patients referring to selective clinics of Shiraz University of Medical Sciences (2009)]. J Arak Univ Med Sci. 2010; 13(3): 12-20. [Article in Persian] 12. Mohamadi J, Havasian MR, Panahi J, Pakzad I. Antifungal drug resistance pattern of Candida. spp isolated from vaginitis in Ilam-Iran during 2013-2014 . Bioinformation 2015; 11(4): 203-6. 13. Macura AB, Skora M. Fungi isolated from the vagina and their susceptibility of antifungals. Ginekol Pol. 2012; 83(6):433-8. 14. Ma CF, Li FQ, Shi LN, Hu YA, Wang Y, Huang M, Kong QQ. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect Dis. 2013 Jul; 13:337. doi:10.1186/1471-2334-13-337 15. Pu S, Niu S, Zhang C, Xu X, Qin M, Huang S, Zhang. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China. J Microbiol Immunol Infect. 2017 Feb; 50(1): 97-103. doi:10.1016/j.jmii.2015.01.005 16. Eleonora Milici M, Massimo Maida C, Spreghini E, Ravazzolo B, Oliveri S, Scalise G, et al. Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin. J Clin Microbiol. 2007 Nov; 45(11): 3529-33. doi:10.1128/JCM.00826-07 17. López-Oviedo E, Aller AI, Martín C, Castro C, Ramirez M, Pemán JM, et al. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method. Antimicrob Agents Chemother. 2006 Mar; 50(3): 1108-11.
|
